Mori M - Search Results

1

Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance.

Iwatsuki M, Mimori K, Ishii H, Yokobori T, Takatsuno Y, Sato T, Toh H, Onoyama I, Nakayama KI, Baba H, Mori M. Iwatsuki M, et al. Among authors: mori m. Int J Cancer. 2010 Apr 15;126(8):1828-1837. doi: 10.1002/ijc.24879. Int J Cancer. 2010. PMID: 19739118

2

Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.

Yamashita K, Tanaka Y, Mimori K, Inoue H, Mori M. Yamashita K, et al. Among authors: mori m. Int J Cancer. 2004 Jun 10;110(2):201-7. doi: 10.1002/ijc.20067. Int J Cancer. 2004. PMID: 15069682

3

Clinicopathologic and prognostic values of apolipoprotein D alterations in hepatocellular carcinoma.

Utsunomiya T, Ogawa K, Yoshinaga K, Ohta M, Yamashita K, Mimori K, Inoue H, Ezaki T, Yoshikawa Y, Mori M. Utsunomiya T, et al. Among authors: mori m. Int J Cancer. 2005 Aug 10;116(1):105-9. doi: 10.1002/ijc.20986. Int J Cancer. 2005. PMID: 15756681

4

Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer.

Ogawa K, Utsunomiya T, Mimori K, Tanaka F, Inoue H, Nagahara H, Murayama S, Mori M. Ogawa K, et al. Among authors: mori m. Clin Cancer Res. 2005 Apr 15;11(8):2889-93. doi: 10.1158/1078-0432.CCR-04-2281. Clin Cancer Res. 2005. PMID: 15837738

5

Clinical significance of TROP2 expression in colorectal cancer.

Ohmachi T, Tanaka F, Mimori K, Inoue H, Yanaga K, Mori M. Ohmachi T, et al. Among authors: mori m. Clin Cancer Res. 2006 May 15;12(10):3057-63. doi: 10.1158/1078-0432.CCR-05-1961. Clin Cancer Res. 2006. PMID: 16707602

6

Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression.

Ieta K, Ojima E, Tanaka F, Nakamura Y, Haraguchi N, Mimori K, Inoue H, Kuwano H, Mori M. Ieta K, et al. Among authors: mori m. Int J Cancer. 2007 Jul 1;121(1):33-8. doi: 10.1002/ijc.22605. Int J Cancer. 2007. PMID: 17354233

7

Clinical significance of the loss of MATS1 mRNA expression in colorectal cancer.

Kosaka Y, Mimori K, Tanaka F, Inoue H, Watanabe M, Mori M. Kosaka Y, et al. Among authors: mori m. Int J Oncol. 2007 Aug;31(2):333-8. Int J Oncol. 2007. PMID: 17611689

8

Clinical significance of growth differentiation factor 11 in colorectal cancer.

Yokoe T, Ohmachi T, Inoue H, Mimori K, Tanaka F, Kusunoki M, Mori M. Yokoe T, et al. Among authors: mori m. Int J Oncol. 2007 Nov;31(5):1097-101. Int J Oncol. 2007. PMID: 17912435

9

Over- and under-expressed microRNAs in human colorectal cancer.

Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K, Mori M. Motoyama K, et al. Among authors: mori m. Int J Oncol. 2009 Apr;34(4):1069-75. doi: 10.3892/ijo_00000233. Int J Oncol. 2009. PMID: 19287964

10

A platinum agent resistance gene, POLB, is a prognostic indicator in colorectal cancer.

Iwatsuki M, Mimori K, Yokobori T, Tanaka F, Tahara K, Inoue H, Baba H, Mori M. Iwatsuki M, et al. Among authors: mori m. J Surg Oncol. 2009 Sep 1;100(3):261-6. doi: 10.1002/jso.21275. J Surg Oncol. 2009. PMID: 19330779

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,990 results

Search Page

Filters